Shuttle Pharmaceuticals Holdings (SHPH) Shares Outstanding (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Shares Outstanding (Entity) of $559129.0 for Q1 2026, up 1291.01% year-over-year from $40196.0 in Q1 2025, and up 241.36% quarter-over-quarter from $163793.0 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Shares Outstanding (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Shares Outstanding (Entity) history runs 6 years deep, the most recent figure standing at $559129.0 for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 1291.01% year-over-year to $559129.0; the TTM figure through Mar 2026 stood at $559129.0 (up 1291.01% YoY), while the FY2025 annual figure was $163793.0, up 1326.77% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $559129.0, up from $163793.0 in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $559129.0 in Q1 2026, with the low at $4659.0 in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $8410.0 (2024), against an average of $69505.5.
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) increased 8.84% in 2024, then jumped 2242.09% in 2025.
- Shuttle Pharmaceuticals Holdings' Shares Outstanding (Entity) stood at $5176.0 in 2022, then jumped by 55.24% to $8035.0 in 2023, then surged by 42.87% to $11480.0 in 2024, then soared by 1326.77% to $163793.0 in 2025, then soared by 241.36% to $559129.0 in 2026.
- Business Quant data shows SHPH's Shares Outstanding (Entity) at $559129.0 in Q1 2026, $163793.0 in Q4 2025, and $223365.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | 832.44 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 1.83 Mn | 1.83 Mn | - | 503,157.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 503,157.00 |
| Dec 31, 2025 | 163,793.00 |
| Sep 30, 2025 | 223,365.00 |
| Jun 30, 2025 | 112,605.00 |
| Mar 31, 2025 | 40,196.00 |
| Dec 31, 2024 | 11,480.00 |
| Sep 30, 2024 | 9,537.00 |
| Jun 30, 2024 | 8,420.00 |
| Mar 31, 2024 | 8,286.00 |
| Dec 31, 2023 | 7,460.00 |
| Sep 30, 2023 | 7,872.00 |
| Jun 30, 2023 | 7,131.00 |
| Mar 31, 2023 | 6,818.00 |
| Dec 31, 2022 | 5,176.00 |
| Sep 30, 2022 | 5,082.00 |
| Jun 30, 2022 | 4,656.00 |
| Mar 31, 2022 | 4,656.00 |
| Dec 31, 2021 | 4,651.00 |
| Sep 30, 2021 | 4,646.00 |